Current treatment for GBM includes surgical resection, radiotherapy, and chemotherapy; targeted or biologically directed approaches such as anti-VEGF therapy (e.g., bevacizumab) and multikinase inhibitors (e.g., regorafenib) have also been explored, although their benefits remain limited in unselected GBM [4]. This evidence concerns the gene VEGFA and glioblastoma.